Cytek Biosciences (CTKB) Inventory Average (2021 - 2026)

Cytek Biosciences has reported Inventory Average for 6 years, with the latest figure at $49.1 million in Q1 2026.

• For the quarter ending Q1 2026, Inventory Average rose 10.06% year-over-year to $49.1 million; the trailing twelve-month figure through Mar 2026 stood at $49.1 million (up 10.06% YoY), and the FY2025 full-year result was $46.2 million, down 11.88% from the prior year.
• Inventory Average for Q1 2026 stood at $49.1 million, down from $50.0 million in the prior quarter.
• The five-year high for Inventory Average was $67.6 million in Q2 2023, with the low at $35.1 million in Q1 2022.
• Historically, Inventory Average has averaged $51.5 million across 5 years, with a median of $49.1 million in 2026.
• Annual changes were most pronounced in 2022 — Inventory Average jumped 74.86% — and 2024, when it decreased 29.01%.
• Cytek Biosciences' Inventory Average stood at $48.8 million in 2022, then jumped by 31.0% to $63.9 million in 2023, then declined by 29.01% to $45.3 million in 2024, then gained by 10.35% to $50.0 million in 2025, then declined by 1.86% to $49.1 million in 2026.
• The last three Inventory Average figures came in at $49.1 million (Q1 2026), $50.0 million (Q4 2025), and $50.6 million (Q3 2025), per Business Quant data.